Legislation
- Title
- Right to Try Act - Individualized Investigational Treatments
- Sponsored by
- Delegates M. Morgan, Alston, Arikan, Bagnall, Chisholm, Fisher, Howard, Hutchinson, S. Johnson, Kerr, Kipke, Pena-Melnyk, Reilly, Szeliga, Bhandari, Cullison, Guzzone, Hill, Kaiser, R. Lewis, Lopez, Martinez, Rosenberg, Taveras, White Holland, and Woods
- Status
- Approved by the Governor - Chapter 960
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Altering certain provisions of law authorizing certain activity by manufacturers of investigational drugs, biological products, or devices under the Right to Try Act to apply to manufacturers of certain individualized investigational treatments; altering the definition of "eligible patient" under the Right to Try Act to include individuals who have life-threatening or severely debilitating illnesses, rather than only individuals who have terminal illnesses; etc.
Committees
Committee Testimony
Details
Bill File Type: Regular
Effective Date(s): October 1, 2024
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
21-2B-01 through 21-2B-06 )
Last Updated: 5/23/2024 5:17 PM